2 results
Approved WMOCompleted
This is a feasibility study of the System to assess safety and performance in patients scheduled to undergo esophagectomy.
Approved WMOCompleted
Compare Progression Free Survival (PFS) for brivanib versus placebo in subjects with advanced solid tumors with FGF-2 over-expression and who have obtained stable disease after 12 weeks of treatment with brivanib separately for each tumor.